The Institute of Public Health (ISP) issued a pharmaceutical alert and reported on the voluntary withdrawal from the market of a specific batch of the product “AltaD Caps Soft Capsules 50,000 IU (Cholecalciferol)”. This measure was taken due to the detection of a serious problem in the state of the capsules, which generated immediate concern in the ISP due to the potential risk to the health of those who consume them.
The ISP issues an alert for a drug
The owner of the health registry itself, Eurofarma Chile SPA, alerted the health authority about the problem. According to the information provided to the ISP, cases were detected containing blister packs with soft capsules in a clear state of deterioration, even showing signs of fusion or melting. For this reason, the ISP focused on detailing the affected lot.
He ISP has been emphatic in detailing the characteristics of the drug compromised so that consumers can quickly identify it and refrain from using it.
- Product: “AltaD Caps Soft Capsules 50,000 IU (Cholecalciferol)”.
- Presentation: Blister with 4 soft capsules per case.
- Affected lot: Serial number “1543539”.
- Expiration date: “12/2026”.
- Manufacturer: Colbrás Indústria e Comércio LTDA (Brazil).
The drug is usually used in adults for the treatment of Vitamin D deficiency, essential for the fixation of calcium in the body and normal bone calcification. However, in the face of physical deterioration, authority, ISPordered his immediate withdrawal.
Vitamin D3 stimulates protein synthesis and is essential for muscle health. Specialists point out that, given the ISP alert, it is crucial not to self-medicate or suspend treatment without first consulting a doctor or pharmacist. He ISP Remember that this product is contraindicated in cases of hypersensitivity to its components, such as cholecalciferol, or if there are pre-existing medical problems.
